Competence in protocol adherence for dosing sessions

The manuals converge on the need for strict protocol adherence during dosing sessions. Across the extracts, the facilitator role is tied to administering the intervention exactly as specified, keeping to predefined session structure, and maintaining consistency so that safety and research outcomes are not compromised. They also share an emphasis on timing and procedural fidelity, whether that means a standardised observation period, fixed dosing procedures, or support aligned with the study schedule. The sources differ in how that adherence is expressed. The ayahuasca trial specifies a single oral dose, a set concentration, an intake time around 10:00 a.m., and an approximately 8 hour session. The GH001 study focuses on single doses at specified levels, individualized dose escalation when indicated, and inhalation or vaporization procedures. The psilocybin versus escitalopram trial centres on two separate psilocybin dosing sessions 3 weeks apart, blinded treatment conditions, and coordination of psychological support with dosing and daily treatment periods.